We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Cellectricon Announces new Opportunity for the Discovery of Highly Differentiated Therapeutics for Alzheimer’s and Parkinson’s Diseases

Product News   Nov 06, 2018

 
Cellectricon Announces new Opportunity for the Discovery of Highly Differentiated Therapeutics for Alzheimer’s and Parkinson’s Diseases
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Horizon Discovery Expands Cell-based CRISPR Screening Services

Product News

Horizon Discovery has announced the addition of an arrayed CRISPR knockout screening service for primary human B cells to its cell-based screening services.

READ MORE

Neoantigen Specific Peptide Synthesis Service for Precision Immuno-oncology Therapeutic Development

Product News

The new service from GenScript aims to overcome the challenges of manufacturing difficult neoantigen peptides critical to personalized cancer vaccine and T-cell therapy generation.

READ MORE

Proteomics Enters the COVID-19 Fight

Product News

SomaLogic has launched a new initiative to deploy their proteomic technology against the coronavirus pandemic.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE